bronchial
epitheli
cell
first
target
cell
rhinoviru
infect
cours
viral
infect
patient
acut
bronchiti
asthma
copd
improv
oral
applic
pelargonium
sidoid
radix
extract
howev
mechan
well
understood
studi
investig
vitro
effect
pelargonium
sidoid
radix
extract
ep
express
viru
bind
cell
membran
host
defenc
support
protein
primari
human
bronchial
epitheli
cell
hbec
cell
isol
patient
sever
asthma
n
moder
copd
n
nondiseas
control
n
protein
express
determin
westernblot
immunofluoresc
rhinoviru
infect
determin
immunofluoresc
well
polymeras
chain
reaction
cell
surviv
determin
manual
cell
count
livedeath
immunofluoresc
stain
paramet
determin
period
day
result
show
ep
concentrationdepend
significantli
increas
hbec
surviv
rhinoviru
infect
effect
parallel
decreas
express
induc
costimul
ico
ligand
icosl
cell
surfac
calreticulin
contrast
ep
upregul
express
host
defenc
support
protein
rhinoviru
infect
uninfect
hbec
express
viru
interact
cell
membran
protein
alter
ep
result
indic
ep
may
reduc
rhinoviru
infect
human
primari
bec
downregul
cell
membran
dock
protein
upregul
host
defenc
protein
bronchial
epitheli
cell
bec
main
target
rhinoviru
infect
frequent
caus
common
cold
well
exacerb
patient
asthma
copd
exacerb
main
caus
diseas
sever
progress
infect
correl
season
frequenc
exacerb
asthma
copd
patient
suggest
prevent
measur
reduc
viral
infect
would
benefit
patient
ep
proprietari
aqueousethanol
extract
pelargonium
sidoid
root
shown
shorten
viral
infect
wide
use
treatment
acut
airway
infect
investig
addon
therapi
asthma
copd
patient
howev
mechan
protect
effect
ep
complet
understood
ep
significantli
reduc
bacteri
viral
infect
immunomodulatori
action
childhood
asthma
day
applic
ep
significantli
improv
symptom
viral
infect
upper
respiratori
tract
acut
bronchiti
cours
ep
improv
symptom
significantli
increas
proport
patient
abl
attend
kindergarten
school
work
day
compar
placebo
ep
demonstr
antivir
effect
broad
panel
respiratori
virus
besid
directli
elimin
virus
may
possibl
prevent
infect
reduc
express
protein
enabl
viru
dock
cell
surfac
regard
lung
diseas
prevent
antivir
strategi
investig
howev
condit
rhinoviru
infect
reduc
block
suggest
molecul
function
dock
protein
support
infect
addit
mediat
rhinovirusinduc
inflamm
asthma
copd
howev
studi
mukhopadhyay
et
al
support
hypothesi
necessari
rhinoviru
infect
describ
copd
induc
costimulatori
ico
ligand
icosl
express
human
bec
hbec
therefor
may
support
function
antigen
present
immun
cell
lung
epitheli
cell
type
ico
express
link
major
histocompat
mediat
antigen
present
concern
asthma
icosl
stimul
airway
smooth
muscl
cell
prolifer
thu
may
contribut
hyperplasia
asthma
epitheli
cell
membran
sever
protein
summar
collectin
express
modifi
immun
respons
infect
protein
form
complex
signal
cell
surfac
calreticulin
ectocalreticulin
calregulin
interestingli
cell
surfac
report
bind
enterovirus
induc
phagocytosi
therebi
increas
antivir
cell
respons
cell
type
epitheli
cell
human
bronchial
epitheli
cell
bacteri
cell
extract
upregul
express
activ
extracellular
mitogen
activ
protein
kinas
human
immun
cell
ep
reduc
express
viru
stimul
secret
upregul
interferon
mitogen
activ
protein
kinas
howev
link
ep
treatment
viru
bind
protein
investig
rhinoviru
context
asthma
copd
rhinoviru
infect
reduc
host
cell
express
immunomodul
bacteri
lysat
upregul
express
mucosa
human
volunt
consequ
viral
infect
determin
howev
observ
highli
express
copd
patient
put
potenti
protect
role
question
copd
patient
frequent
suffer
exacerb
due
viral
infect
includ
rhinoviru
childhood
asthma
use
bacteri
extract
increas
express
correl
reduc
exacerbationinfect
rate
rhinoviru
infect
increas
suppressor
cytokin
signal
upregul
transform
growth
factor
bec
suggest
antivir
effect
asthma
express
neg
correl
induc
cytokin
secret
bec
thu
result
latter
studi
also
indic
differ
strain
rhinoviru
may
distinct
effect
host
defenc
mechan
monocyt
rhinoviru
upregul
express
mrna
level
correl
reduc
secret
antiinflammatori
cytokin
therefor
role
respons
rhinoviru
infect
may
cell
type
specif
investig
studi
assess
effect
ep
express
cell
membran
protein
may
play
role
rhinoviru
infect
antivir
host
defenc
protein
primari
hbec
patient
asthma
copd
well
nondiseas
control
studi
cohort
consist
healthi
proband
n
asthma
n
copd
n
patient
healthi
control
select
patient
undergo
diagnost
bronchial
biopsi
reason
asthma
copd
ethic
approv
obtain
requir
tissu
sampl
approv
local
ethic
committe
ek
nordwest
und
zentralschweiz
eknz
basec
patient
gave
written
inform
consent
tissu
obtain
either
nondiseas
lung
tissu
obtain
patient
undergo
lung
resect
lung
metastasi
cancer
therapi
thorac
surgeri
univers
hospit
basel
basel
switzerland
asthma
patient
classifi
mildsev
accord
gina
guidelin
pneumolog
clinic
univers
hospit
basel
basel
switzerland
copd
patient
classifi
accord
gold
guidelin
pneumolog
clinic
univers
hospit
basel
basel
switzerland
patient
acut
exacerb
known
viralbacteri
infect
exclud
tissu
donor
characterist
display
tabl
ep
suppli
schwabe
pharma
ag
rigi
compound
dissolv
cell
cultur
medium
final
concentr
appli
cell
cultur
publish
earlier
small
piec
bronchial
tissu
x
x
mm
place
cell
cultur
vessel
prewet
bec
specif
medium
cntpra
cellntech
bern
switzerland
medium
replac
everi
second
day
cell
passag
mechan
shake
divid
cell
cell
characteris
posit
stain
ecadherin
pankeratin
neg
stain
fibronectin
cell
treat
either
ep
andor
infect
rv
hour
stain
live
ratio
live
blue
dead
green
cell
accord
manufactur
instruct
molecular
probe
mammalian
cell
viabil
thermofish
scientif
switzerland
cell
incub
minut
doubl
stain
solut
monitor
photograph
evo
cell
imag
system
thermofish
scientif
ratio
green
blue
cell
count
calcul
percentag
total
cell
rv
strain
use
experi
describ
earlier
identifi
experi
describ
use
stock
describ
earlier
hbec
infect
multipl
infect
moi
day
infect
rate
determin
immunofluoresc
stain
use
antibodi
cat
qedbiosci
inc
san
diego
usa
cell
seed
chamber
slide
thermofish
scientif
switzerland
treat
either
andor
ep
indic
treatment
schemata
provid
fig
treatment
cell
fix
formalin
pb
minut
wash
pb
fix
cell
wash
pb
permeabilis
minut
pb
unspecif
bind
block
bovin
serum
albumin
minut
pb
incub
overnight
c
antibodi
dilut
follow
wash
pb
cell
incub
antimous
fitc
label
antibodi
abcam
switzerland
hour
room
temperatur
wash
pb
number
posit
cell
count
immunofluoresc
microscopi
evo
floid
cell
imag
station
thermofish
scientif
nuclei
stain
cell
count
use
distributor
live
cell
reagent
thermofish
scientif
polymeras
chain
reaction
perform
follow
primer
ccc
tga
atg
ygg
cta
aca
cgg
aca
ccc
aaa
gta
follow
protocol
describ
other
pcr
product
analys
gel
electrophoresi
immunoblot
protein
analysi
describ
earlier
follow
protein
separ
gradient
polyacrylamid
gel
electroblot
onto
pvdf
membran
protein
identifi
express
rate
determin
westernblot
follow
protein
detect
ico
icosl
soc
abcam
cambridg
uk
detail
dilut
produc
provid
tabl
membran
block
hour
room
temperatur
pb
contain
bovin
serum
albumin
primari
antibodi
ad
concentr
indic
tabl
incub
overnight
follow
wash
block
buffer
membran
incub
secondari
speci
specif
antibodi
label
hors
radish
peroxidas
hour
unbound
antibodi
wash
wash
block
buffer
protein
band
visualis
exposur
xray
film
gapdh
express
use
normal
protein
express
estim
chang
induc
differ
treatment
confluent
cell
treat
either
ep
combin
hr
cell
wash
pb
fix
x
minut
paraformaldehyd
minut
block
cell
bovin
serum
albumin
cell
incub
overnight
one
list
antibodi
tabl
cell
wash
x
pb
incub
horseradish
label
secondari
speci
specif
antibodi
hour
room
temperatur
addit
wash
pb
bound
antibodi
detect
ad
tmbsubstrat
minut
reaction
top
ad
n
hcl
absorb
read
nm
data
display
optic
densiti
arbitrari
unit
method
describ
earlier
immunofluoresc
analysi
cell
seed
chamber
slide
cat
sarstedt
ag
sevelen
switzerland
follow
hour
serum
depriv
cell
pretreat
ep
minut
follow
infect
moiml
variou
time
point
day
end
infect
period
cell
fix
paraformaldehyd
pb
x
min
immunofluoresc
stain
perform
describ
previous
primari
antibodi
tabl
dilut
bsapb
incub
overnight
follow
wash
subsequ
stain
pelabel
goat
antirabbit
igg
secondari
antibodi
fitclabel
goat
antimous
igg
secondari
antibodi
santa
cruz
biotechnolog
inc
ca
nuclei
stain
dapi
imag
captur
evo
floid
cell
imag
station
nuclei
stain
cell
count
use
distributor
live
cell
reagent
nucblu
tm
cat
thermofish
scientif
nullhypothesi
effect
ep
express
cell
surfac
protein
express
rhinoviru
infect
cell
surviv
treat
cell
compar
nontreat
cell
rhinoviru
infect
cell
pvalu
calcul
anova
student
ttest
pair
twotail
pvalu
consid
significantli
differ
control
use
human
primari
bronchial
epitheli
cell
smooth
muscl
cell
control
n
asthma
n
copd
n
effect
ep
express
viru
dock
protein
rhinoviru
infect
assess
scheme
treatment
primari
epitheli
cell
shown
fig
epitheli
cell
incub
one
infecti
unit
iu
hour
infect
determin
immunofluoresc
stain
infect
period
shorter
hour
show
signific
effect
surviv
posit
hbec
infect
significantli
reduc
surviv
hbec
hour
effect
reduc
hbec
preincub
ep
concentr
depend
manner
fig
diseas
specif
effect
observ
rescu
effect
ep
infect
infect
hour
depict
repres
phasecontrast
microscopi
photograph
fig
infect
drug
treatment
epitheli
cell
show
characterist
knobbleston
phenotyp
fig
file
ep
alon
fig
file
second
row
alter
phenotyp
hour
infect
significantli
reduc
cell
number
fig
file
rd
row
st
photograph
preincub
hour
ep
cell
surviv
increas
infect
infect
concentrationdepend
reduc
ep
fig
file
rd
th
row
infect
also
monitor
immunefluoresc
stain
intens
stain
quantifi
comput
assist
imag
analysi
program
fig
furthermor
depict
repres
pcrgel
reduc
express
rvrna
hour
treatment
ep
fig
insert
result
immunostain
show
signific
reduct
follow
hour
preincub
ep
fig
protect
effect
ep
increas
time
becam
signific
lower
concentr
hr
fig
b
file
diseas
specif
effect
observ
compar
effect
ep
control
asthma
copd
cell
fig
show
repres
pcrproduct
gel
reduc
express
hour
treatment
ep
primari
hbec
pretreat
ep
hour
distinct
effect
express
viral
dock
protein
shown
fig
ep
decreas
express
ico
base
line
level
untreat
hbec
determin
westernblot
subsequ
imag
analysi
protein
band
effect
compound
concentr
depend
also
occur
hbec
infect
hour
treatment
ep
fig
signific
differ
overal
benefici
effect
ep
three
group
hbec
howev
control
need
higher
concentr
ep
reduc
ico
express
fig
infect
alon
slightli
increas
express
ico
compar
untreat
cell
effect
signific
fig
similar
ico
express
ligand
icosl
reduc
ep
concentr
depend
manner
three
hbec
group
fig
reduc
effect
ep
icosl
express
stronger
hbec
asthma
patient
infect
effect
express
icosl
fig
reduc
effect
ep
icosl
express
also
observ
infect
hbec
fig
repres
immunoblot
present
insert
fig
complet
immunoblot
shown
support
inform
tabl
b
fig
c
file
depict
fluoresc
microscopi
untreat
hbec
express
cytosol
cell
membran
fig
three
day
treatment
ep
express
reduc
remain
protein
shift
cytosol
fig
second
panel
infect
stimul
accumul
cellular
membran
major
hbec
fig
third
panel
reduc
effect
ep
reloc
affect
infect
fig
fourth
panel
reduc
effect
ep
express
confirm
westernblot
show
concentr
depend
effect
fig
westernblot
imag
analysi
suggest
increas
express
hbec
asthma
copd
donor
compar
healthi
tissu
donor
howev
overal
inhibit
ep
document
group
fig
repres
immunoblot
present
insert
fig
complet
immunoblot
shown
support
inform
tabl
fig
b
file
report
affect
express
describ
data
avail
effect
hbec
infect
significantli
affect
express
period
three
day
ep
concentr
bar
repres
od
mean
semof
six
independ
experi
differ
cell
line
group
c
indic
untreat
hbec
indic
pvalu
compar
control
indic
pvalu
compar
infect
hbec
c
indic
untreat
hbec
indic
pvalu
compar
control
indic
pvalu
compar
infect
hbec
repres
immunoblot
present
insert
fig
complet
data
immunoblot
shown
support
inform
tabl
b
depend
increas
express
fig
hbec
pretreat
ep
afterward
infect
express
still
upregul
three
donor
group
fig
stimulatori
effect
ep
stronger
cell
obtain
patient
asthma
copd
compar
control
fig
increas
ep
could
also
detect
immunofluoresc
microscopi
shown
fig
ep
increas
express
second
host
defenc
protein
concentr
depend
manner
shown
fig
increas
ep
similar
three
hbec
group
fig
infect
slightli
reduc
express
effect
signific
compar
untreat
hbec
fig
cell
pretreat
hour
ep
infect
signific
effect
increas
express
shown
fig
fluoresc
microscopi
confirm
increas
hbec
expos
ep
fig
present
data
suggest
ep
reduc
rhinoviru
infect
modif
hbec
function
benefici
effect
ep
rhinoviru
infect
may
part
explain
neteffect
compound
reduc
potenti
rhinoviru
dock
protein
simultan
increas
express
host
defenc
system
thu
infect
rate
reduc
intracellular
kill
rhinoviru
may
increas
preincub
ep
significantli
reduc
signal
infect
epitheli
cell
indic
reduc
viru
replic
find
line
report
show
ep
reduc
replic
influenzaa
viru
respiratori
syncyti
viru
corona
viru
parainfluenza
viru
coxsacki
viru
reduct
viral
replic
ep
may
explain
benefici
effect
drug
acut
respiratori
tract
infect
children
reduc
frequenc
exacerb
copd
patient
cell
membran
report
mediat
viru
phagocytosi
enterovirus
led
intracellular
kill
upregul
day
treatment
bacteri
extract
report
earlier
human
bronchial
epitheli
cell
link
reduc
infect
studi
observ
ep
downregul
three
day
cell
type
result
may
oppos
may
lead
reduc
viru
infect
long
role
viral
infect
unclear
increas
intracellular
kill
phagocytosi
well
reduc
dock
rv
might
result
lower
infect
host
cell
ico
ligand
icosl
discuss
possibl
target
tool
improv
viru
defenc
fact
ico
icosl
express
differ
type
lung
epitheli
cell
report
other
howev
first
report
demonstr
express
ico
icosl
reduc
immun
modul
ep
also
cell
infect
effect
ep
occur
togeth
reduc
infect
rate
howev
proof
studi
event
link
alveolar
cell
hbec
respiratori
syncyti
viru
upregul
ico
express
assum
ico
function
bind
protein
virus
enterovirus
increas
express
ico
report
immun
cell
organ
epitheli
cell
specif
express
ico
icosl
affect
immun
cell
function
therebi
contribut
host
respons
inhibit
ico
icosl
discuss
time
also
regard
asthma
associ
host
immun
toler
howev
yet
therapeut
applic
develop
blockad
ico
icosl
signal
synthet
inhibitor
icoslg
report
diseas
anim
model
report
inhibit
icosicosl
significantli
reduc
inflamm
furthermor
icosl
stimul
prolifer
airway
smooth
muscl
cell
inhibit
may
reduc
airway
wall
remodel
asthma
thu
downregul
express
ico
icosl
hbec
ep
may
two
benefici
effect
chronic
inflammatori
lung
diseas
reduc
abil
rhinoviru
bind
host
epitheli
cell
surfac
prevent
infect
ii
reduc
immun
cell
mediat
inflamm
two
effect
respons
clinic
report
reduc
viral
infect
ep
investig
futur
studi
howev
direct
evid
proinfecti
effect
ico
icosl
viru
infect
miss
effect
ep
express
name
host
cell
viral
dock
defenc
protein
clearli
seen
analys
immunofluoresc
immunoblot
thu
indic
compound
modifi
cell
compartment
locat
viral
dock
defenc
protein
within
cell
rather
induc
de
novo
synthesi
observ
modifi
express
viru
dock
protein
epitheli
cell
suggest
applic
ep
sever
day
may
reduc
infect
rate
rhinoviru
howev
present
data
also
indic
effect
ep
may
cell
type
specif
contribut
benefici
effect
ep
host
defenc
rhinoviru
infect
observ
upregul
hour
find
suggest
host
cell
may
stimul
execut
intracellular
kill
rhinoviru
effect
data
may
also
explain
observ
improv
surviv
host
cell
incub
day
ep
infect
howev
role
defenc
rhinoviru
infect
unclear
literatur
provid
exampl
proinfecti
effect
well
viru
protect
describ
describ
reduc
viral
infect
differ
cell
type
inform
effect
rhinoviru
infect
hbec
infect
slightli
reduc
express
effect
achiev
signific
contrast
ep
upregul
express
absenc
presenc
increas
express
correl
decreas
infect
hbec
studi
could
provid
proof
causal
link
event
differ
describ
help
clearanc
viral
bacteri
infect
without
stimul
inflamm
thu
interest
target
therapi
infecti
diseas
speci
report
act
adjuv
viru
vaccin
includ
influenza
hepat
viru
herp
viru
carp
viru
summaris
kalenik
et
al
howev
mechan
protect
host
cell
infect
well
studi
conclus
ep
reduc
viral
dock
protein
without
show
diseas
specif
effect
find
support
concept
ep
applic
reduc
suscept
rvinfect
describ
molecular
biolog
vitro
result
may
fig
one
day
incub
ep
stimul
express
antivir
cell
surfac
protein
c
indic
untreat
hbec
indic
pvalu
compar
control
indic
pvalu
compar
infect
hbec
b
repres
immunofluoresc
photograph
express
primari
human
epitheli
cell
presenc
absenc
ep
three
day
primari
human
hbec
healthi
control
similar
result
obtain
hbec
obtain
patient
moderatesever
asthma
copd
bar
repres
od
mean
semof
six
independ
experi
differ
cell
line
group
c
indic
untreat
hbec
indic
pvalu
compar
control
indic
pvalu
compar
infect
hbec
repres
immunoblot
present
insert
fig
complet
data
immunoblot
shown
support
inform
tabl
